VI-RADS score system - A primer for urologists

Int Braz J Urol. 2022 Jul-Aug;48(4):609-622. doi: 10.1590/S1677-5538.IBJU.2021.0560.

Abstract

Bladder cancer (BCa) is one of the most common cancers worldwide and is also considered to be one of the most relapsing and aggressive neoplasms. About 30% of patients will present with muscle invasive disease, which is associated with a higher risk for metastatic disease. The aim of this article is to review the state of art imaging in Radiology, while providing a complete guide to urologists, with case examples, for the rationale of the development of the Vesical Imaging Reporting and Data System (VI-RADS), a scoring system emphasizing a standardized approach to multiparametric Magnetic Resonance Imaging (mpMRI) acquisition, interpretation, and reporting for BCa. Also, we examine relevant external validation studies and the consolidated literature of mpMRI for bladder cancer. In addition, this article discusses some of the potential clinical implications of this scoring system for disease management and follow-up.

Keywords: Diffusion Magnetic Resonance Imaging; Genitourinary Tract Anomalies [Supplementary Concept]; Urinary Bladder Neoplasms.

Publication types

  • Review

MeSH terms

  • Humans
  • Magnetic Resonance Imaging / methods
  • Multiparametric Magnetic Resonance Imaging*
  • Neoplasm Recurrence, Local / pathology
  • Urinary Bladder / pathology
  • Urinary Bladder Neoplasms* / diagnostic imaging
  • Urinary Bladder Neoplasms* / pathology
  • Urologists